VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 75 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,180,105 | -35.6% | 859,095 | -0.2% | 0.00% | 0.0% |
| Q2 2023 | $20,479,795 | +3.7% | 860,857 | +10.9% | 0.00% | -33.3% |
| Q1 2023 | $19,744,298 | +94975.4% | 776,112 | +9.2% | 0.00% | 0.0% |
| Q4 2022 | $20,767 | -99.8% | 710,985 | +18.5% | 0.00% | +50.0% |
| Q3 2022 | $12,301,000 | +136.5% | 599,766 | +33.4% | 0.00% | +100.0% |
| Q2 2022 | $5,202,000 | +41.2% | 449,660 | +125.7% | 0.00% | – |
| Q1 2022 | $3,683,000 | -7.6% | 199,238 | -1.2% | 0.00% | – |
| Q4 2021 | $3,987,000 | +295.9% | 201,678 | +229.3% | 0.00% | – |
| Q3 2021 | $1,007,000 | +43.9% | 61,250 | +60.0% | 0.00% | – |
| Q2 2021 | $700,000 | +83.2% | 38,283 | +67.2% | 0.00% | – |
| Q1 2021 | $382,000 | – | 22,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |